Profiles of obese children presenting for metabolic evaluation

J Anavian1, D J Brenner, P Fort

  • 1Department of Pediatrics, North Shore University Hospital, North Shore-Long Island Jewish Health System, New York University School of Medicine, USA.

Insights

Childhood obesity is linked to family history of obesity and type 2 diabetes. Mild hypercholesterolemia and insulin insensitivity are common, particularly in adolescents.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Health

Background:

  • Childhood obesity is a growing concern, leading to earlier onset of type 2 diabetes mellitus (DM).
  • Family history of obesity and diabetes are significant risk factors in pediatric populations.

Purpose of the Study:

  • To investigate the correlations between childhood obesity and family history.
  • To analyze anthropomorphic, dietary, exercise, and endocrine/metabolic patterns in obese children.

Main Methods:

  • Chart review of 106 children aged 3-18 years, divided into four age groups.
  • Data collection included anthropometrics, family history, lifestyle factors, and endocrine/metabolic markers.
  • Descriptive statistics were employed to analyze the data.

Main Results:

  • Parental obesity correlated with higher percent ideal body weight (IBW) in children (p=0.01).
  • 58% of children had relatives with type 2 DM; 9% with type 1 DM.
  • Elevated cholesterol (mean 176 mg/dl) and increasing insulin resistance with age were observed; thyroid dysfunction was rare.

Conclusions:

  • Childhood obesity is associated with family history of obesity and diabetes.
  • Mild hypercholesterolemia and insulin insensitivity are prevalent, especially in adolescent populations.
  • Thyroid dysfunction is uncommon in this cohort.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...